Notice of Full Year 2022 financial results
Leiden, The Netherlands, February 28, 2023
Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) confirms it will announce its unaudited Full Year 2022 financial results for the year ended December 31, 2022, on Thursday, March 16, 2023.
The Company will host a presentation for analysts and investors at 13:30 CET/08:30 ET on March 16, 2023. Dial in details for the presentation are detailed below.
Conference call dial-in information
March 16, 2023
13:30 CET/08:30 ET
Please note, the Company will only take questions from dial-in attendees